Evidence map›Paper›PMID 40815318›Full record

ReviewDer Nervenarzt2025

[Challenges and chances in the management of methamphetamine-related disorders].

Maximilian Pilhatsch, Johannes Petzold, Maik Spreer

Abstract readReviewEnglish Abstract
PubMed Publisher
In one paragraph

Review in Der Nervenarzt, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maximilian PilhatschKlinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Carl Gustav Carus Dresden, Medizinische Fakultät Dresden, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland. maximilian.pilhatsch@ukdd.de.
Johannes PetzoldKlinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Carl Gustav Carus Dresden, Medizinische Fakultät Dresden, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland.
Maik SpreerKlinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Carl Gustav Carus Dresden, Medizinische Fakultät Dresden, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methamphetamine (MA) is one of the most relevant illegal drugs of our time worldwide. In German hospitals the management of a variety of MA-associated problems are also part of the daily routine, especially in the central area of Germany. A rapid infiltration of the central nervous system, pronounced dopaminergic stimulation and a long-term effect together with easy availability are the reasons for the enormous potential for dependency. This review article shows the dimensions and complexity of MA-related disorders (MRD). Proven diagnostic and therapeutic knowledge is reported and approaches for a possible sustainable solution to the problems are named.

Indexed as

Amphetamine-Related DisordersCentral Nervous System StimulantsMethamphetamineGermanyHumansCentral Nervous System StimulantsMethamphetamineComorbiditiesDependency potentialDiagnosticsMode of actionPregnancy

Identifiers

PMID40815318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.